NCT00720226
Efficacy of Losartan in Preventing Progression of COPD
See it on ClinicalTrials.gov ↗106 people
50%
50%
53 womenmiddle line = equal numbers53 men
- Phase
- PHASE4
- Paid for by
- Johns Hopkins University
- Finished
- 2016-08
- Health conditions
- COPD, Emphysema, Chronic Bronchitis, Smoking
- Who could join
- Anyone
- Ages
- 40 Years – no maximum
- Average age
- mean 58.8 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 71.7% · Black / African American 28.3% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.